ALTEPLASE FOR HEPATIC VENOOCCLUSIVE DISEASE COMPLICATING BONE-MARROW TRANSPLANTATION

被引：31

作者：

LAPORTE, JP ^{[1
]}

LESAGE, S ^{[1
]}

TILLEUL, P ^{[1
]}

NAJMAN, A ^{[1
]}

GORIN, NC ^{[1
]}

机构：

[1] HOP ST ANTOINE,DEPT PHARM,F-75571 PARIS,FRANCE

来源：

LANCET | 1992年 / 339卷 / 8800期

关键词：

D O I：

10.1016/0140-6736(92)90579-R

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1057 / 1057

页数：1

共 7 条

[1]

BAGLIN TP, 1990, BONE MARROW TRANSPL, V5, P439

[2] REGIMEN-RELATED TOXICITY IN PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION [J].

BEARMAN, SI ;

APPELBAUM, FR ;

BUCKNER, CD ;

PETERSEN, FB ;

FISHER, LD ;

CLIFT, RA ;

THOMAS, ED .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (10) :1562-1568

[3] USE OF PROSTAGLANDIN-E1 FOR PREVENTION OF LIVER VENOOCCLUSIVE DISEASE IN LEUKEMIC PATIENTS TREATED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].

GLUCKMAN, E ;

JOLIVET, I ;

SCROBOHACI, ML ;

DEVERGIE, A ;

TRAINEAU, R ;

BOURDEAUESPEROU, H ;

LEHN, P ;

FAURE, P ;

DROUET, L .

BRITISH JOURNAL OF HAEMATOLOGY, 1990, 74 (03) :277-281

[4]

MARSAVILA L, 1991, EUR J HAEMATOL, V47, P346

[5] VENO-OCCLUSIVE DISEASE OF THE LIVER AFTER BONE-MARROW TRANSPLANTATION - DIAGNOSIS, INCIDENCE, AND PREDISPOSING FACTORS [J].

MCDONALD, GB ;

SHARMA, P ;

MATTHEWS, DE ;

SHULMAN, HM ;

THOMAS, ED .

HEPATOLOGY, 1984, 4 (01) :116-122

[6]

RIO B, 1986, BLOOD, V67, P1773

[7]

SHULMAN HM, 1987, AM J PATHOL, V127, P549

← 1 →